Cisco
CSCO
Alibaba
BABA
Disney
DIS
Apple
AAPL
Qualcomm
QCOM
US Stock MarketDetailed Quotes
OPRX OptimizeRx
- 8.740
- -0.730-7.71%
Close Mar 26 16:00 ET
- 8.740
- 0.0000.00%
Post 16:05 ET
161.61MMarket Cap-7.95P/E (TTM)
9.410High8.710Low263.35KVolume9.410Open9.470Pre Close2.37MTurnover1.85%Turnover RatioLossP/E (Static)18.49MShares14.13052wk High1.38P/B124.78MFloat Cap3.78052wk Low--Dividend TTM14.28MShs Float99.178Historical High--Div YieldTTM7.39%Amplitude3.780Historical Low8.984Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
OptimizeRx Stock Forum
OptimizeRx Doubles Enterprise Deals, Projects $100M Revenue as Subscription Model Takes Off
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its strategic relationship with a major pharma client, resulting in a multi-solution, multi-brand program with a total in-year commitment of over $10 million. This includes the previously mentioned $6 million DAAP contract, which is still undergoing ...
No comment yet